Karagiannis Athanasios

Oncologist Karagiannis Athanasios, at the Athens Bioclinic, is responsible for the complete design and administration of systemic (intravenous or oral) therapy such as classic chemotherapy and primarily immunotherapy and targeted molecular therapy, based on the results of molecular testing conducted on the tumor of each specific patient, aiming for individualized therapeutic selection in accordance with global guidelines, thus providing patients suffering from cancer access to the latest therapeutic options in immunotherapy and targeted therapy.

He also actively participates in the oncology board, through which decisions are made that determine the overall therapeutic approach to managing a malignant disease. This includes, besides systemic therapy, radiotherapy, surgical removal, and various local treatments (thermal ablation, embolization). The medical team of the oncology board includes physicians from all specialties involved in treating a malignant disease, such as surgical oncologists, radiation oncologists, interventional radiologists, internists, and pathologists, offering a comprehensive assessment of the disease, its treatment, and potential complications during the overall therapeutic course.

In our Oncology Department, numerous patients with lung cancer, stomach and intestinal cancer, pancreatic, liver, and biliary tract cancer, bladder and kidney cancer, and breast cancer are monitored.

Additionally, emphasis is placed on the complex therapeutic management of metastatic and advanced cancers through the simultaneous application of systemic and local therapies (directly to the metastatic site) in collaboration with the specialized interventional radiology department of the Athens Bioclinic.